SunWay Biotech Co., LTD. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 176.11 million compared to TWD 153.37 million a year ago. Net income was TWD 79.66 million compared to TWD 64.22 million a year ago.

Basic earnings per share from continuing operations was TWD 2.4 compared to TWD 1.94 a year ago. Diluted earnings per share from continuing operations was TWD 2.36 compared to TWD 1.91 a year ago.